Interferon Gamma Release Assays (IGRA) in the Diagnosis of Active Pulmonary Tuberculosis

Background: Tuberculosis is one of the deadliest diseases over the world. Diagnosis of pulmonary TB depends on combination various parameters. IGRA measure T cell release of IFN-γ in response to M.TB antigen. WHO policy statement as on IGRA use in low and middle income countries is not established...

Full description

Bibliographic Details
Main Authors: Mona K. EL-Deeb, Hatem A. EL Malwany, Yehia M. Khalil, Saher T. Mourad
Format: Article
Language:English
Published: Alexandria University 2014-06-01
Series:Journal of High Institute of Public Health
Subjects:
_version_ 1828899163740307456
author Mona K. EL-Deeb
Hatem A. EL Malwany
Yehia M. Khalil
Saher T. Mourad
author_facet Mona K. EL-Deeb
Hatem A. EL Malwany
Yehia M. Khalil
Saher T. Mourad
author_sort Mona K. EL-Deeb
collection DOAJ
description Background: Tuberculosis is one of the deadliest diseases over the world. Diagnosis of pulmonary TB depends on combination various parameters. IGRA measure T cell release of IFN-γ in response to M.TB antigen. WHO policy statement as on IGRA use in low and middle income countries is not established yet. Objective: The present study aimed to compare between tuberculin skin test (TST) and interferon gamma release assay (IGRA) in the diagnosis of active tuberculosis infection and study the effect of 3 months of first line anti-TB therapy on the positivity of the IGRA test. Methods: 40 Egyptian patients were included in the study, and assigned as two groups; Group I comprised 20 patients with negative sputum for AFB by Ziehl-Neelsen stains with positive sputum culture for M.TB and Group II included 20 patients with positive sputum and Ziehl-Neelsen for AFB before and after 3 months of first line of anti-TB therapy. All patients were subjected to full history taking, clinical examination, X- ray chest, lab investigations, ESR measurements, microbiological tests and ELISA measurement of Quantiferon-TB Gold. Results: Lower significant values were found in group II after treatment than before treatment regarding clinical parameters and 1st and 2nd hours ESR. IGRA test and TST showed sensitivity (91.18%, 76.4%), specificity (83.33%, 66.67%), positive predictive value (96.88%, 92.86%), negative predictive value (62.5%, 33.3%) and accuracy of (90%, 75%) respectively. IGRA results had no statistical significant differences between the studied groups with poor agreement with TST ((κ) = 0.025). Conclusion: IGRAS test had high sensitivity and specificity in diagnosis of active TB. More studies are needed to evaluate the effect of anti-TB therapy on IGRA level.
first_indexed 2024-12-13T15:26:35Z
format Article
id doaj.art-b46ab13ad5b54351a7c852c61d492a48
institution Directory Open Access Journal
issn 2357-0601
2357-061X
language English
last_indexed 2024-12-13T15:26:35Z
publishDate 2014-06-01
publisher Alexandria University
record_format Article
series Journal of High Institute of Public Health
spelling doaj.art-b46ab13ad5b54351a7c852c61d492a482022-12-21T23:40:19ZengAlexandria UniversityJournal of High Institute of Public Health2357-06012357-061X2014-06-01441334010.21608/JHIPH.2014.20355Interferon Gamma Release Assays (IGRA) in the Diagnosis of Active Pulmonary TuberculosisMona K. EL-Deeb0Hatem A. EL Malwany1Yehia M. Khalil2Saher T. Mourad3Chemical Pathology Department, Medical Research Institute, Alexandria University, EgyptChest Diseases Department, Faculty of Medicine, Alexandria University, EgyptChest Diseases Department, Faculty of Medicine, Alexandria University, EgyptChest Diseases Department, Faculty of Medicine, Alexandria University, EgyptBackground: Tuberculosis is one of the deadliest diseases over the world. Diagnosis of pulmonary TB depends on combination various parameters. IGRA measure T cell release of IFN-γ in response to M.TB antigen. WHO policy statement as on IGRA use in low and middle income countries is not established yet. Objective: The present study aimed to compare between tuberculin skin test (TST) and interferon gamma release assay (IGRA) in the diagnosis of active tuberculosis infection and study the effect of 3 months of first line anti-TB therapy on the positivity of the IGRA test. Methods: 40 Egyptian patients were included in the study, and assigned as two groups; Group I comprised 20 patients with negative sputum for AFB by Ziehl-Neelsen stains with positive sputum culture for M.TB and Group II included 20 patients with positive sputum and Ziehl-Neelsen for AFB before and after 3 months of first line of anti-TB therapy. All patients were subjected to full history taking, clinical examination, X- ray chest, lab investigations, ESR measurements, microbiological tests and ELISA measurement of Quantiferon-TB Gold. Results: Lower significant values were found in group II after treatment than before treatment regarding clinical parameters and 1st and 2nd hours ESR. IGRA test and TST showed sensitivity (91.18%, 76.4%), specificity (83.33%, 66.67%), positive predictive value (96.88%, 92.86%), negative predictive value (62.5%, 33.3%) and accuracy of (90%, 75%) respectively. IGRA results had no statistical significant differences between the studied groups with poor agreement with TST ((κ) = 0.025). Conclusion: IGRAS test had high sensitivity and specificity in diagnosis of active TB. More studies are needed to evaluate the effect of anti-TB therapy on IGRA level.interferon gamma release assays (igra)tuberculosis (tb)tuberculin skin test (tst)
spellingShingle Mona K. EL-Deeb
Hatem A. EL Malwany
Yehia M. Khalil
Saher T. Mourad
Interferon Gamma Release Assays (IGRA) in the Diagnosis of Active Pulmonary Tuberculosis
Journal of High Institute of Public Health
interferon gamma release assays (igra)
tuberculosis (tb)
tuberculin skin test (tst)
title Interferon Gamma Release Assays (IGRA) in the Diagnosis of Active Pulmonary Tuberculosis
title_full Interferon Gamma Release Assays (IGRA) in the Diagnosis of Active Pulmonary Tuberculosis
title_fullStr Interferon Gamma Release Assays (IGRA) in the Diagnosis of Active Pulmonary Tuberculosis
title_full_unstemmed Interferon Gamma Release Assays (IGRA) in the Diagnosis of Active Pulmonary Tuberculosis
title_short Interferon Gamma Release Assays (IGRA) in the Diagnosis of Active Pulmonary Tuberculosis
title_sort interferon gamma release assays igra in the diagnosis of active pulmonary tuberculosis
topic interferon gamma release assays (igra)
tuberculosis (tb)
tuberculin skin test (tst)
work_keys_str_mv AT monakeldeeb interferongammareleaseassaysigrainthediagnosisofactivepulmonarytuberculosis
AT hatemaelmalwany interferongammareleaseassaysigrainthediagnosisofactivepulmonarytuberculosis
AT yehiamkhalil interferongammareleaseassaysigrainthediagnosisofactivepulmonarytuberculosis
AT sahertmourad interferongammareleaseassaysigrainthediagnosisofactivepulmonarytuberculosis